NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Vivo Capital’

21 May 2015

Vivo Capital, Venrock help gene therapy business Regenxbio to weighty $70.5m Series D

microscope pic Gene therapy-focused biotech business Regenxbio has closed a hefty $70.5m Series D financing round thanks to investment from firms including Vivo Capital and Venrock.

10 April 2015

Antibiotics researcher Nabriva gets $120m Vivo Capital, OrbiMed-led Series B

Nabriva Antibiotics research pioneer Nabriva Therapeutics has picked up a huge $120m Series B round from investors including Vivo Capital and OrbiMed.

19 March 2015

Vivo closes its eighth fund on $750m

heart monitor medical healthcare Healthcare-focused Vivo Capital has closed its oversubscribed eighth fund on $750m, twice the size of its previous.

6 February 2015

Vivo closes eighth healthcare fund on $600m

drug-pharma-medical-healthcare Healthcare focused investment firm Vivo Capital has raisied a little over its target of $600m for its eight fund , AltAssets can reveal.

1 December 2014

Growth hormone deficiency treatment company Ascendis picks up $60m VC-backed Series D

drug tablet pill medical pharma Sofinnova Ventures has joined with OrbiMed and Vivo Capital to lead a $60m Series D financing round for biotech business Ascendis Pharma.

21 May 2014

KKR joins investors in biotherapeutics developer Coherus BioSciences

Coherus BioSciences, a US biologics platform company focused on biosimilars, has closed a Series C round raising $55m from investors including KKR, Venrock, RA Capital Management, Rock Springs Capital and Fidelity Biosciences.

22 April 2014

Vivo Capital leads $58.5m Series D for ProNAi Therapeutics

biotech_lrg Nucleic acid therapeutics developer ProNAi Therapeutics has secured $59.5m in a Series D round led by venture capital firm Vivo Capital.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015